Reliance Chemotex Industries Ltd Upgraded to Sell Amid Mixed Technicals and Weak Fundamentals

Technical Trends Spark Upgrade

The primary catalyst for the rating upgrade lies in the technical analysis of Reliance Chemotex’s stock price movements. The technical grade shifted from bearish to mildly bearish, signalling a tentative improvement in market momentum. Weekly MACD readings turned mildly bullish, suggesting a nascent positive momentum in the near term, although monthly MACD remains bearish, indicating caution over a longer horizon.

Other technical indicators present a mixed picture. The weekly KST (Know Sure Thing) and Dow Theory signals have turned mildly bullish, reinforcing the short-term optimism. Conversely, monthly KST and Dow Theory remain bearish, reflecting ongoing structural weakness. The Relative Strength Index (RSI) on both weekly and monthly charts shows no clear signal, while Bollinger Bands maintain a mildly bearish stance on both timeframes.

Moving averages on a daily basis continue to be bearish, and the On-Balance Volume (OBV) indicator is mildly bearish weekly with no discernible monthly trend. This combination of signals suggests that while short-term technical momentum has improved enough to warrant a rating upgrade, the overall technical outlook remains cautious.

Financial Trend Remains Flat and Concerning

Despite the technical improvement, Reliance Chemotex’s financial performance remains underwhelming. The company reported flat results for Q3 FY25-26, with net sales at ₹81.94 crores, marking a decline of 10.5% compared to the previous four-quarter average. Operating profit growth over the last five years has been modest at 19.57% annually, while net sales have grown at a rate of 7.89% per annum, indicating slow expansion in a competitive garments and apparels sector.

Return on Capital Employed (ROCE) stands at a weak 9.25% on average, reflecting limited efficiency in generating returns from invested capital. The company’s ability to service debt is also a concern, with a high Debt to EBITDA ratio of 8.15 times, signalling elevated leverage and financial risk. These factors contribute to the company’s weak long-term fundamental strength and justify the retention of a Sell rating despite the technical upgrade.

Valuation Appears Attractive Amidst Challenges

On the valuation front, Reliance Chemotex presents a contrasting picture. The company’s ROCE of 4.5% combined with an enterprise value to capital employed ratio of 0.9 suggests a very attractive valuation relative to its capital base. The stock is trading at a discount compared to its peers’ historical valuations, which may appeal to value-oriented investors.

Moreover, despite a negative stock return of -23.70% over the past year, the company’s profits have surged by 101.1%, resulting in a low PEG ratio of 0.2. This indicates that earnings growth is not yet reflected in the share price, potentially signalling an undervaluation. However, the persistent underperformance against benchmarks such as the BSE500 and Sensex over multiple periods tempers enthusiasm.

Stock Performance and Market Comparison

Reliance Chemotex’s stock price closed at ₹118.00 on 8 April 2026, up 4.89% from the previous close of ₹112.50. The stock’s 52-week high and low stand at ₹211.65 and ₹109.80 respectively, highlighting significant volatility. Over the last week, the stock returned 5.08%, slightly underperforming the Sensex’s 6.06% gain. Over one month, the stock was essentially flat (-0.04%) while the Sensex declined by 1.72%.

Year-to-date, Reliance Chemotex has declined by 11.58%, underperforming the Sensex’s 8.99% loss. Over one year, the stock has fallen 23.70%, in stark contrast to the Sensex’s 4.49% gain. Longer-term returns over three and five years also lag the benchmark, with the stock down 35.69% over three years versus the Sensex’s 29.63% gain, and a 51.38% gain over five years compared to the Sensex’s 55.92%. Over ten years, the stock has appreciated 194.19%, slightly below the Sensex’s 214.35% rise.

Quality Assessment and Shareholding

Reliance Chemotex’s quality grade remains low, reflected in its micro-cap market capitalisation and weak financial ratios. The company’s promoter group holds the majority stake, which provides some stability but also concentrates risk. The garment and apparel sector is highly competitive, and Reliance Chemotex’s modest growth and profitability metrics suggest it faces challenges in scaling operations and improving margins.

While the recent technical improvements have prompted a rating upgrade, the company’s fundamental quality remains poor, with limited evidence of sustainable growth or financial strength. Investors should weigh the technical optimism against the persistent fundamental weaknesses before considering exposure.

Conclusion: A Cautious Upgrade Amidst Mixed Signals

The upgrade of Reliance Chemotex Industries Ltd’s investment rating from Strong Sell to Sell reflects a nuanced view of the company’s prospects. Technical indicators have improved sufficiently to reduce bearishness, signalling potential short-term price support. However, the company’s flat financial performance, weak return metrics, high leverage, and consistent underperformance relative to benchmarks maintain a negative fundamental outlook.

Valuation metrics suggest the stock is attractively priced relative to peers, which may offer some upside potential if earnings growth continues to accelerate. Nonetheless, the overall assessment remains cautious, with the Sell rating indicating that investors should remain wary and consider alternative opportunities with stronger fundamentals and more robust technical trends.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today